Noted that epigenetic modifiers such as DTAI (DNMT3A, TET2, ASXL1, and/or IDH1 or IDH2) are the most prevalent AML-initiating mutation and the combination of them may confer clonal dominance. The gene discussed is ASXL1; the disease is acute myeloid leukemia.